Liberation Bioindustries pauses plant construction over $25m funding gap
· Agriculture & Food · United States
Liberation Bioindustries has paused construction at its purpose-built 600,000-liter facility in Richmond, Indiana, as it seeks an additional $25 million to complete the project. The company said it has received "no acceptable offers" as it works to plug the funding gap. The plant is designed as a large-scale precision fermentation site, a category of biomanufacturing that has attracted heavy investment in recent years. The halt leaves the project's completion timeline uncertain and puts the company's expansion plans on hold until new capital is secured.
Why it matters:Precision fermentation developers are discovering that scaling from pilot to commercial volumes requires capital that is proving hard to raise, a risk for the whole alternative-protein supply chain.
Key points
- The Richmond, Indiana facility is designed for 600,000 liters of capacity.
- The company is seeking $25 million to finish construction.
- No acceptable offers have been received so far.
Sources (original reporting)
More stories from this day
- Bidder files letter of intent for Believer Meats' US cultivated meat plant
- Hershey targets $1bn in Dot's pretzel sales through new categories
- American Express cuts 5% of workforce in AI restructuring
- Peak Energy raises $108M for sodium-ion battery storage
- Moderna-Merck melanoma vaccine cuts recurrence or death by 42%
- FAA Orders Inspections of Nearly 2,000 Boeing 737 Next Generation Jets